WO2003061625A3 - Sustained release ophthalmological device and method of making and using the same - Google Patents
Sustained release ophthalmological device and method of making and using the same Download PDFInfo
- Publication number
- WO2003061625A3 WO2003061625A3 PCT/US2003/001388 US0301388W WO03061625A3 WO 2003061625 A3 WO2003061625 A3 WO 2003061625A3 US 0301388 W US0301388 W US 0301388W WO 03061625 A3 WO03061625 A3 WO 03061625A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- making
- same
- sustained release
- ophthalmological device
- implant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/147—Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1694—Capsular bag spreaders therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
- A61F2002/1683—Intraocular lenses having supporting structure for lens, e.g. haptics having filiform haptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
- A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/901—Method of manufacturing prosthetic device
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0415630A GB2399753B (en) | 2002-01-18 | 2003-01-17 | Method of making a sustained release ophthalmological device |
CA2473355A CA2473355C (en) | 2002-01-18 | 2003-01-17 | Sustained release ophthalmological device and method of making and using the same |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34946502P | 2002-01-18 | 2002-01-18 | |
US60/349.465 | 2002-01-18 | ||
US39769802P | 2002-07-22 | 2002-07-22 | |
US60/397,698 | 2002-07-22 | ||
US10/346,671 US7090888B2 (en) | 2002-01-18 | 2003-01-17 | Sustained release ophthalmological device and method of making and using the same |
US10/346,671 | 2003-01-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003061625A2 WO2003061625A2 (en) | 2003-07-31 |
WO2003061625A3 true WO2003061625A3 (en) | 2004-09-16 |
Family
ID=27617576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/001388 WO2003061625A2 (en) | 2002-01-18 | 2003-01-17 | Sustained release ophthalmological device and method of making and using the same |
Country Status (4)
Country | Link |
---|---|
US (2) | US7090888B2 (en) |
CA (1) | CA2473355C (en) |
GB (1) | GB2399753B (en) |
WO (1) | WO2003061625A2 (en) |
Families Citing this family (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
EP2316394B1 (en) | 2001-06-12 | 2016-11-23 | The Johns Hopkins University | Reservoir device for intraocular drug delivery |
GB2399753B (en) | 2002-01-18 | 2006-04-19 | Michael E Snyder | Method of making a sustained release ophthalmological device |
US7951392B2 (en) * | 2002-08-16 | 2011-05-31 | Boston Scientific Scimed, Inc. | Microarray drug delivery coatings |
US8404269B2 (en) | 2003-04-11 | 2013-03-26 | Michael Snyder | Sustained release implantable eye device |
US7435256B2 (en) * | 2003-11-06 | 2008-10-14 | Boston Scientific Scimed, Inc. | Method and apparatus for controlled delivery of active substance |
US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
US7597678B2 (en) * | 2004-07-09 | 2009-10-06 | Brown David C | Apparatus and methods for isolating lens capsule fluids |
PT1781264E (en) | 2004-08-04 | 2013-10-16 | Evonik Corp | Methods for manufacturing delivery devices and devices thereof |
US20060034884A1 (en) * | 2004-08-10 | 2006-02-16 | Stenzel Eric B | Coated medical device having an increased coating surface area |
WO2006057859A1 (en) * | 2004-11-24 | 2006-06-01 | Therakine Corporation | An implant for intraocular drug delivery |
US8221824B2 (en) * | 2005-02-03 | 2012-07-17 | Boston Scientific Scimed, Inc. | Deforming surface of drug eluting coating to alter drug release profile of a medical device |
US20120179249A1 (en) * | 2005-07-21 | 2012-07-12 | Cornell University | Accommodating intraocular lens and methods of use |
DK2004172T3 (en) * | 2006-03-31 | 2019-04-23 | Mati Therapeutics Inc | PHARMACEUTICAL ADMINISTRATION STRUCTURES AND COMPOSITIONS FOR NASOLACRIMAL SYSTEM |
US7981096B2 (en) * | 2006-05-12 | 2011-07-19 | David Castillejos | Optic nerve head implant and medication delivery system |
WO2007139808A2 (en) * | 2006-05-25 | 2007-12-06 | Ayyala Ramesh S | Device for delivery of antifibrotic agents & method |
US20070292468A1 (en) * | 2006-06-14 | 2007-12-20 | Joel Studin | Coated jewelry articles to reduce skin irritation |
KR100807940B1 (en) * | 2007-03-08 | 2008-02-28 | 박경진 | Intraocular lens |
KR100807939B1 (en) * | 2007-03-08 | 2008-02-28 | 박경진 | Lens assembly |
WO2008112935A1 (en) * | 2007-03-13 | 2008-09-18 | University Of Rochester | Intraocular pressure regulating device |
EP2134350A1 (en) * | 2007-03-14 | 2009-12-23 | The University of Washington | Device and method for intraocular drug delivery |
US20080311177A1 (en) | 2007-06-14 | 2008-12-18 | Massachusetts Institute Of Technology | Self Assembled Films for Protein and Drug Delivery Applications |
JP5502751B2 (en) | 2007-12-20 | 2014-05-28 | エボニック コーポレイション | Process for preparing microparticles with low residual solvent concentration |
US20090196905A1 (en) * | 2008-02-06 | 2009-08-06 | Spada Lon T | Stabilization of mitochondrial membranes in ocular diseases and conditions |
CN102026599A (en) | 2008-05-12 | 2011-04-20 | 犹他大学研究基金会 | Intraocular drug delivery device and associated methods |
US10588855B2 (en) | 2008-05-12 | 2020-03-17 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US10064819B2 (en) | 2008-05-12 | 2018-09-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US9095404B2 (en) | 2008-05-12 | 2015-08-04 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
US9877973B2 (en) | 2008-05-12 | 2018-01-30 | University Of Utah Research Foundation | Intraocular drug delivery device and associated methods |
TWI531362B (en) | 2008-07-21 | 2016-05-01 | 艾爾康股份有限公司 | Ophthalmic device having therapeutic agent delivery capability |
WO2010021973A2 (en) | 2008-08-17 | 2010-02-25 | Massachusetts Institute Of Technology | Controlled delivery of bioactive agents from decomposable films |
US20100119519A1 (en) * | 2008-11-13 | 2010-05-13 | Peyman Gholam A | Ophthalmic drug delivery system and method |
US10842669B2 (en) | 2008-11-13 | 2020-11-24 | Gholam A. Peyman | Ophthalmic drug delivery method |
US10272035B2 (en) | 2008-11-13 | 2019-04-30 | Gholam A. Peyman | Ophthalmic drug delivery method |
US20110125090A1 (en) * | 2008-11-13 | 2011-05-26 | Peyman Gholam A | Ophthalmic drug delivery system and method |
US20120232649A1 (en) | 2008-11-20 | 2012-09-13 | Insight Innovations, Llc | Intraocular Lens Cell Migration Inhibition System |
WO2010059214A2 (en) * | 2008-11-20 | 2010-05-27 | Insight Innovations, Llc | Biocompatible biodegradable intraocular implant system |
US8551167B2 (en) * | 2008-11-20 | 2013-10-08 | Insight Innovations, Llc | Intraocular implant cell migration inhibition system |
US9943402B2 (en) | 2008-11-20 | 2018-04-17 | Insight Innovations, Llc | Micropatterned intraocular implant |
EP2361060A4 (en) | 2008-11-26 | 2014-02-26 | Anew Optics Inc | Haptic devices for intraocular lens |
US10010405B2 (en) | 2008-11-26 | 2018-07-03 | Anew Aol Technologies, Inc. | Haptic devices for intraocular lens |
US20110313522A1 (en) * | 2008-11-26 | 2011-12-22 | Anew Optics, Inc. | Pseudophakic Accommodating Intraocular Lens |
US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
ES2747755T3 (en) | 2009-01-29 | 2020-03-11 | Forsight Vision4 Inc | Administration of a drug to the posterior segment |
WO2010093945A2 (en) * | 2009-02-13 | 2010-08-19 | Glaukos Corporation | Uveoscleral drug delivery implant and methods for implanting the same |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
WO2012071476A2 (en) | 2010-11-24 | 2012-05-31 | David Haffner | Drug eluting ocular implant |
CN102596097B (en) | 2009-06-03 | 2015-05-20 | 弗赛特实验室有限责任公司 | Anterior segment drug delivery |
JP5570515B2 (en) * | 2009-09-30 | 2014-08-13 | テルモ株式会社 | Stent |
CN102740900A (en) * | 2010-01-21 | 2012-10-17 | 首尔大学校产学协力团 | Method for coating medication on medical article |
EP2566468A4 (en) * | 2010-05-03 | 2014-06-18 | Massachusetts Inst Technology | Drug delivery coating and devices |
WO2011162896A1 (en) * | 2010-06-21 | 2011-12-29 | Novartis Ag | Intraocular rings and associated systems and methods |
SI2600930T1 (en) | 2010-08-05 | 2021-08-31 | Forsight Vision4, Inc. | Injector apparatus for drug delivery |
EP2600876B1 (en) | 2010-08-05 | 2015-04-29 | Forsight Vision4, Inc. | Combined drug delivery methods and apparatus |
CN103209664A (en) | 2010-08-05 | 2013-07-17 | 弗赛特影像4股份有限公司 | Implantable therapeutic device |
AU2011329656B2 (en) | 2010-11-19 | 2017-01-05 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
EP2726016B1 (en) | 2011-06-28 | 2023-07-19 | ForSight Vision4, Inc. | An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye |
EP2739252A4 (en) | 2011-08-05 | 2015-08-12 | Forsight Vision4 Inc | Small molecule delivery with implantable therapeutic device |
KR102071083B1 (en) | 2011-09-14 | 2020-01-29 | 포사이트 비젼5, 인크. | Ocular insert apparatus and methods |
PT2755600T (en) | 2011-09-16 | 2021-04-19 | Forsight Vision4 Inc | Fluid exchange apparatus and methods |
WO2013116061A1 (en) | 2012-02-03 | 2013-08-08 | Forsight Vision4, Inc. | Insertion and removal methods and apparatus for therapeutic devices |
US8900300B1 (en) | 2012-02-22 | 2014-12-02 | Omega Ophthalmics Llc | Prosthetic capsular bag and method of inserting the same |
WO2013163234A1 (en) | 2012-04-23 | 2013-10-31 | Massachusetts Institute Of Technology | Stable layer-by-layer coated particles |
CN104884006B (en) | 2012-10-26 | 2017-12-15 | 弗赛特影像5股份有限公司 | Ophthalmic system for sustained release drugs to eyes |
WO2014134029A1 (en) | 2013-02-26 | 2014-09-04 | Massachusetts Institute Of Technology | Nucleic acid particles, methods and use thereof |
CA2905496A1 (en) | 2013-03-14 | 2014-09-25 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
US9463244B2 (en) | 2013-03-15 | 2016-10-11 | Massachusetts Institute Of Technology | Compositions and methods for nucleic acid delivery |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
JP6385423B2 (en) | 2013-03-28 | 2018-09-05 | フォーサイト・ビジョン フォー・インコーポレーテッド | Ocular graft for therapeutic substance delivery |
CN103340703A (en) * | 2013-06-17 | 2013-10-09 | 无锡蕾明视康科技有限公司 | Implantable myopia lens and preparation method thereof |
EA032183B1 (en) * | 2013-11-14 | 2019-04-30 | Айд Фарма | Intraocular drug delivery device, process for preparing same and methods of using same |
WO2015184173A1 (en) | 2014-05-29 | 2015-12-03 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
EP4029474A1 (en) | 2014-06-19 | 2022-07-20 | Omega Ophthalmics LLC | Prosthetic capsular devices |
CN106687079B (en) | 2014-07-15 | 2019-10-11 | 弗赛特影像4股份有限公司 | Eyes are implanted into conveying device and method |
MY182793A (en) | 2014-08-08 | 2021-02-05 | Forsight Vision4 Inc | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
US20160128828A1 (en) * | 2014-11-09 | 2016-05-12 | Rajesh Dalvi | Exocapsular device and method for lens stabilization |
SG11201703726XA (en) | 2014-11-10 | 2017-06-29 | Forsight Vision4 Inc | Expandable drug delivery devices and method of use |
FR3028410A1 (en) | 2014-11-18 | 2016-05-20 | Pierre Coulon | MULTIFUNCTIONAL CAPSULAR IMPLANT |
US9358103B1 (en) | 2015-02-10 | 2016-06-07 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
FR3033694A1 (en) * | 2015-03-17 | 2016-09-23 | Pierre Coulon | IMPLANT OF OCULAR SULCUS |
US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11564833B2 (en) | 2015-09-25 | 2023-01-31 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
KR20180084104A (en) | 2015-11-20 | 2018-07-24 | 포사이트 비젼4, 인크. | Porous structures for extended release drug delivery devices |
WO2017176886A1 (en) | 2016-04-05 | 2017-10-12 | Forsight Vision4, Inc. | Implantable ocular drug delivery devices |
CN109937025B (en) | 2016-04-20 | 2022-07-29 | 多斯医学公司 | Delivery device for bioabsorbable ocular drugs |
EP3463044A4 (en) | 2016-05-31 | 2020-07-29 | Qura, Inc. | Implantable intraocular pressure sensors and methods of use |
CA3026494C (en) | 2016-06-06 | 2022-06-07 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
AU2017345731B2 (en) | 2016-10-21 | 2019-10-24 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
DE102017112087A1 (en) | 2017-06-01 | 2018-12-06 | Carl Zeiss Meditec Ag | Artificial eye lens with laser-generated birefringent structure and method for producing an artificial eye lens |
DE102017112085A1 (en) * | 2017-06-01 | 2018-12-06 | Carl Zeiss Meditec Ag | Artificial eye lens with medicament depot formed therein and method for making an artificial eye lens |
DE102017112086A1 (en) | 2017-06-01 | 2018-12-06 | Carl Zeiss Meditec Ag | Artificial eye lens with diffractive grating structure and method for producing an artificial eye lens |
WO2019089567A1 (en) | 2017-10-30 | 2019-05-09 | Massachusetts Institute Of Technology | Layer-by-layer nanoparticles for cytokine therapy in cancer treatment |
CN111655206B (en) | 2017-11-21 | 2022-10-14 | 弗赛特影像4股份有限公司 | Fluid exchange device for expandable port delivery system and method of use |
EP3773334A4 (en) | 2018-04-06 | 2021-12-29 | Omega Ophthalmics LLC | Prosthetic capsular devices, systems, and methods |
JP2021532853A (en) | 2018-07-23 | 2021-12-02 | ザ リージェンツ オブ ザ ユニヴァーシティ オブ コロラド,ア ボディ コーポレイト | Ophthalmic device for drug delivery |
WO2020046299A1 (en) * | 2018-08-30 | 2020-03-05 | Qura, Inc. | Implantable intraocular drug delivery devices |
JP2022538347A (en) | 2019-06-27 | 2022-09-01 | レイヤーバイオ,インコーポレーテッド | Ophthalmic device delivery method and system |
CN110584874B (en) * | 2019-08-26 | 2022-05-06 | 江苏百视通医疗器械有限公司 | Implant conveying device |
US11399977B2 (en) | 2020-06-04 | 2022-08-02 | SpyGlass Pharma, Inc. | Ophthalmic implant system for drug delivery |
AU2021359888A1 (en) | 2020-10-12 | 2023-06-15 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
WO2023147224A1 (en) * | 2022-01-31 | 2023-08-03 | Alcon Inc. | Adjustable intraocular lenses and methods of post‑operatively adjusting intraocular lenses |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0544948A1 (en) * | 1989-03-23 | 1993-06-09 | University Of Miami | Intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
US5554187A (en) * | 1995-08-18 | 1996-09-10 | Rizzo, Iii; Joseph | Medication dispensing intra-ocular lens system |
US5743274A (en) * | 1996-03-18 | 1998-04-28 | Peyman; Gholam A. | Macular bandage for use in the treatment of subretinal neovascular members |
US5843186A (en) * | 1996-12-20 | 1998-12-01 | Implemed, Inc. | Intraocular lens with antimicrobial activity |
US5980928A (en) * | 1997-07-29 | 1999-11-09 | Terry; Paul B. | Implant for preventing conjunctivitis in cattle |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3993071A (en) * | 1971-09-09 | 1976-11-23 | Alza Corporation | Bioerodible ocular device |
US3828777A (en) * | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
US4292965A (en) * | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
US5616122A (en) | 1986-11-04 | 1997-04-01 | Baylor College Of Medicine | Methods and compositions for preventing secondary cataracts |
US4863457A (en) * | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
US5401880A (en) | 1987-06-04 | 1995-03-28 | Oculon Corporation | Chemical prevention or reversal of cataract by phase separation inhibitors |
US4853224A (en) | 1987-12-22 | 1989-08-01 | Visionex | Biodegradable ocular implants |
US5273751A (en) | 1988-03-25 | 1993-12-28 | Seymour Dubroff | Composition for preventing clouding of paosterior capsule after extracapsular cataract eye surgery and method of performing cataract surgery |
US4936825A (en) * | 1988-04-11 | 1990-06-26 | Ungerleider Bruce A | Method for reducing intraocular pressure caused by glaucoma |
WO1991017724A1 (en) | 1990-05-17 | 1991-11-28 | Harbor Medical Devices, Inc. | Medical device polymer |
US5762638A (en) * | 1991-02-27 | 1998-06-09 | Shikani; Alain H. | Anti-infective and anti-inflammatory releasing systems for medical devices |
US5300020A (en) * | 1991-05-31 | 1994-04-05 | Medflex Corporation | Surgically implantable device for glaucoma relief |
US5375611A (en) | 1993-01-26 | 1994-12-27 | Pharmacia Ab | Method for preventing secondary cataract |
US5876438A (en) | 1993-08-02 | 1999-03-02 | Houston Biotechnology Incorporated | Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract |
DE4341442C2 (en) * | 1993-12-04 | 1998-11-05 | Lohmann Therapie Syst Lts | Device for the controlled release of active substances and their use |
US6051576A (en) * | 1994-01-28 | 2000-04-18 | University Of Kentucky Research Foundation | Means to achieve sustained release of synergistic drugs by conjugation |
US5843760A (en) * | 1994-04-15 | 1998-12-01 | Midwest Research Institute | Single zymomonas mobilis strain for xylose and arabinose fermentation |
US5624704A (en) | 1995-04-24 | 1997-04-29 | Baylor College Of Medicine | Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent |
US5820917A (en) * | 1995-06-07 | 1998-10-13 | Medtronic, Inc. | Blood-contacting medical device and method |
WO1997012564A1 (en) * | 1995-10-06 | 1997-04-10 | Cumming J Stuart | Intraocular lenses with fixated haptics |
US6558686B1 (en) | 1995-11-08 | 2003-05-06 | Baylor College Of Medicine | Method of coating medical devices with a combination of antiseptics and antiseptic coating therefor |
FR2743496B1 (en) | 1996-01-15 | 1998-04-10 | Univ Rennes | MACROPOROUS COMPOSITE SUPPORT FOR DRUG SUBSTANCE (S) FOR USE AS BONE RECONSTRUCTION MATERIAL AND PROCESS FOR PREPARING THE SAME |
EP0920273B1 (en) * | 1996-07-15 | 2000-01-05 | Otto Koch | Device for preparation of hen's eggs |
US6428572B2 (en) * | 1998-01-12 | 2002-08-06 | Menicon Co., Ltd. | Intraocular ring |
US5843184A (en) | 1998-01-26 | 1998-12-01 | Cionni; Robert J. | Endocapsular tension ring and method of implanting same |
US20020099438A1 (en) * | 1998-04-15 | 2002-07-25 | Furst Joseph G. | Irradiated stent coating |
US6206916B1 (en) * | 1998-04-15 | 2001-03-27 | Joseph G. Furst | Coated intraluminal graft |
US6196993B1 (en) | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
US20020065546A1 (en) * | 1998-12-31 | 2002-05-30 | Machan Lindsay S. | Stent grafts with bioactive coatings |
KR20010018344A (en) * | 1999-08-19 | 2001-03-05 | 임승정 | A capsalar tension ring for cataract operation |
US6264971B1 (en) * | 1999-11-04 | 2001-07-24 | Btg International Limited | Ocular insert |
US6352542B1 (en) | 2000-03-08 | 2002-03-05 | Michael E. Snyder | Intraocular lens with improved haptic and method of implanting same |
PT1313415E (en) * | 2000-08-30 | 2008-11-25 | Univ Johns Hopkins | Devices for intraocular drug delivery |
JP2004514702A (en) * | 2000-11-29 | 2004-05-20 | オキュレックス ファーマシューティカルズ, インコーポレイテッド | Intraocular implant for preventing transplant rejection in the eye |
EP2316394B1 (en) | 2001-06-12 | 2016-11-23 | The Johns Hopkins University | Reservoir device for intraocular drug delivery |
GB2399753B (en) | 2002-01-18 | 2006-04-19 | Michael E Snyder | Method of making a sustained release ophthalmological device |
-
2003
- 2003-01-17 GB GB0415630A patent/GB2399753B/en not_active Expired - Fee Related
- 2003-01-17 WO PCT/US2003/001388 patent/WO2003061625A2/en not_active Application Discontinuation
- 2003-01-17 CA CA2473355A patent/CA2473355C/en not_active Expired - Fee Related
- 2003-01-17 US US10/346,671 patent/US7090888B2/en not_active Expired - Fee Related
-
2006
- 2006-07-14 US US11/457,628 patent/US20060246112A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0544948A1 (en) * | 1989-03-23 | 1993-06-09 | University Of Miami | Intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
US5554187A (en) * | 1995-08-18 | 1996-09-10 | Rizzo, Iii; Joseph | Medication dispensing intra-ocular lens system |
US5743274A (en) * | 1996-03-18 | 1998-04-28 | Peyman; Gholam A. | Macular bandage for use in the treatment of subretinal neovascular members |
US5843186A (en) * | 1996-12-20 | 1998-12-01 | Implemed, Inc. | Intraocular lens with antimicrobial activity |
US5980928A (en) * | 1997-07-29 | 1999-11-09 | Terry; Paul B. | Implant for preventing conjunctivitis in cattle |
Also Published As
Publication number | Publication date |
---|---|
GB0415630D0 (en) | 2004-08-18 |
US7090888B2 (en) | 2006-08-15 |
CA2473355C (en) | 2012-01-03 |
GB2399753B (en) | 2006-04-19 |
GB2399753A (en) | 2004-09-29 |
US20030149479A1 (en) | 2003-08-07 |
CA2473355A1 (en) | 2003-07-31 |
WO2003061625A2 (en) | 2003-07-31 |
US20060246112A1 (en) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003061625A3 (en) | Sustained release ophthalmological device and method of making and using the same | |
WO2003074551A3 (en) | Conjugates of therapeutic or cytotoxic agents and biologically active peptides | |
MXPA03003895A (en) | Controlled release hydrocodone formulations. | |
WO2005011770A3 (en) | Biologically absorbable coatings for implantable devices | |
WO2002067895A3 (en) | Implant dosage form and use thereof for the delivery of a cholesterol lowering agent | |
PL334656A1 (en) | Dosage forms and methods of achieving betterement in cases of erection disorderamong male patients | |
WO2004036186A3 (en) | Microencapsulation and sustained release of biologically active polypeptides | |
AU2003274681A1 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
AU2001263229A1 (en) | Compositions and methods for administration of pharmacologically active compounds | |
HUP0301465A2 (en) | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition | |
WO2004030678A8 (en) | Polymer compositions containing bioactive agents and methods for their use | |
WO2005007139A3 (en) | Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form | |
AU2003215245A1 (en) | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof | |
WO1998047485A3 (en) | Apatite-coated solid composition | |
AU2001267809A1 (en) | Method and device for the manufacture of the medical expanding stents | |
WO1999044608A8 (en) | New use | |
HK1040920A1 (en) | Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent. | |
HRP20041193A2 (en) | Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release | |
EP1575987A4 (en) | Conjugates of membrane translocating agents and pharmaceutically active agents | |
AU2003281469A1 (en) | Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof | |
AU2002251831A1 (en) | Methods for sustained release local delivery of drugs for ablation of unwanted tissue | |
AU2001252225A1 (en) | Oral composition comprising chlorhexinine and maltitol or erythritol or a mixture thereof | |
CA2324254A1 (en) | Sustained-release composition including amorphous polymer | |
AU2003302188A1 (en) | Method of obtaining a soothing active ingredient, active ingredient and compositions obtained | |
HUP0204417A2 (en) | Oral ciprofloxacin-composition of controlled release |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 0415630 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20030117 |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2473355 Country of ref document: CA |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |